HALO logo
halo search icon
Alzamend Neuro, Inc.
Alzamend Neuro, Inc.
ALZN · NAS

Alzamend Neuro, Inc.

US$1.20

Price Arrow0.19 (18.81%)
20/05/2026 04:00:01 PM
All-CompaniesAll-ConsensusBig Candle (Realtime)HALO AllHALO Capital EfficiencyHALO Consensus ValueHammer BearishHammer Bullish+1
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Alzamend Neuro, Inc. Overview

ALZN Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Weak

Earnings

Weak

Growth

Earnings

Neutral

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About ALZN

icon

Website

Alzamend Neuro, Inc.

icon

Telephone

1.844.722.6333

icon

Address

2nd Floor, Suite 103, 3480 Peachtree Road NE, Atlanta, GA 30326

Description

Alzamend Neuro, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing products for the treatment of neurodegenerative and psychiatric disorders. The company's pipeline includes AL001, which is in Phase II clinical trial, and delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bipolar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders, and AL002, which completed preclinical stage, and uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. The company was founded on February 26, 2016 by Milton C. Ault, III and is headquartered in Atlanta, GA.

ALZN Price Chart

Key Stats

Market Cap

US$3.84M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.84 - 8.22

Trade Value (12mth)

US$533,894.00

1 week

-0.98%

1 month

-5.61%

YTD

-46.84%

1 year

-71.31%

All time high

45292.50

Key Fundamentals

EPS 3 yr Growth

-94.80%

EBITDA Margin

0.00%

Operating Cashflow

-$7m

Free Cash Flow Return

0.00%

ROIC

0.00%

Interest Coverage

0.00

Quick Ratio

0.00

Other Data

Shares Outstanding (Fully Diluted)

4m

HALO Sector

Healthcare

Next Company Report Date

01-Jul-26

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

ALZN Announcements

Latest Announcements

DateAnnouncements
18 April 26
18 April 26
21 March 26
12 March 26
12 March 26

ALZN Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-132.33-11.32-10.67locklocklock
EPS (Fully Diluted)
$locklocklocklock-132.33-11.32N/Alocklocklock
Growth
%locklocklocklock35.891.45.8locklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Alzamend Neuro, Inc. (ALZN:NAS)?
Halo FAQ
The current share price of Alzamend Neuro, Inc. (ALZN:NAS) is USD$1.20.
What is the 52-week high share price for Alzamend Neuro, Inc. (ALZN:NAS)?
Halo FAQ
The 52-week high share price for Alzamend Neuro, Inc. (ALZN:NAS) is USD$8.22.
What is the 52-week low share price for Alzamend Neuro, Inc. (ALZN:NAS)?
Halo FAQ
The 52-week low share price for Alzamend Neuro, Inc. (ALZN:NAS) is USD$0.84.
What is the dividend yield for Alzamend Neuro, Inc. (ALZN:NAS)?
Halo FAQ
Alzamend Neuro, Inc. (ALZN:NAS) does not pay a dividend.
What was Alzamend Neuro, Inc. (ALZN:NAS) last dividend payment?
Halo FAQ
Alzamend Neuro, Inc. (ALZN:NAS) does not pay a dividend.
What is the franking level for Alzamend Neuro, Inc. (ALZN:NAS)?
Halo FAQ
Alzamend Neuro, Inc. (ALZN:NAS) has a franking level of 0.00%.
In which sector is Alzamend Neuro, Inc. (ALZN:NAS) classified?
Halo FAQ
Alzamend Neuro, Inc. (ALZN:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.